Nano Pharmaceutical Industry and Market

Nanopharmaceuticals represent an emerging field and offer the capacity to distinguish sicknesses at considerably prior stages and the diagnostic applications could expand upon conventional techniques utilizing nanoparticles, Nano-empowered medical items have had their effect on the areas, for example, cancer, CNS diseases, cardiovascular diseases, and infection control. While nano-upgraded drug delivery items are now a business reality, more progressed nanotech-based medical gadgets are still being developed, although some are at the clinical testing stage. A large portion of the money being spent on the more extensive field of nanotechnology R&D originates from government and built up enterprises. In the nanomedicine field, pharmaceutical and specialist organizations are at the front line of research into the therapeutic uses of nanotechnology.

The global nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The market is expected to grow to $107.6 billion by 2016 and is expected to reach 130bn in 2019 at a compound annual growth rate (CAGR) of 14.1.